Page last updated: 2024-10-26

eicosapentaenoic acid ethyl ester and Blood Coagulation Disorders

eicosapentaenoic acid ethyl ester has been researched along with Blood Coagulation Disorders in 2 studies

Blood Coagulation Disorders: Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.

Research Excerpts

ExcerptRelevanceReference
"We investigated the effect of long-term administration of highly purified eicosapentaenoic acid ethyl ester (EPA-E), an n-3 polyunsaturated fatty acid, on the development of diabetes, insulin resistance, and abnormalities of blood coagulation in male WBN/Kob rats, a model of spontaneous diabetes mellitus."3.70Long-term administration of highly purified eicosapentaenoic acid ethyl ester prevents diabetes and abnormalities of blood coagulation in male WBN/Kob rats. ( Ishikawa, T; Nobukata, H; Obata, M; Shibutani, Y, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mori, Y1
Nobukata, H2
Harada, T1
Kasahara, T1
Tajima, N1
Ishikawa, T1
Obata, M1
Shibutani, Y1

Other Studies

2 other studies available for eicosapentaenoic acid ethyl ester and Blood Coagulation Disorders

ArticleYear
Long-term administration of highly purified eicosapentaenoic acid ethyl ester improves blood coagulation abnormalities and dysfunction of vascular endothelial cells in Otsuka Long-Evans Tokushima fatty rats.
    Endocrine journal, 2003, Volume: 50, Issue:5

    Topics: Animals; Arteries; Blood Coagulation Disorders; Cell Movement; Drug Administration Schedule; Eicosap

2003
Long-term administration of highly purified eicosapentaenoic acid ethyl ester prevents diabetes and abnormalities of blood coagulation in male WBN/Kob rats.
    Metabolism: clinical and experimental, 2000, Volume: 49, Issue:7

    Topics: Animals; Blood Coagulation Disorders; Diabetes Mellitus; Eicosapentaenoic Acid; Fibrinolysis; Glucos

2000